Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)

NCT03345901 is registered in ClinicalTrials.gov with Jaeb Center for Health Research as lead sponsor.

NCT NCT03345901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03345901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROMINENT-Eye Ancillary Study: Diabetic Retinopathy Outcomes in a Randomized Trial of Pemafibrate Versus Placebo (Protocol AD)
Lead sponsor
Jaeb Center for Health Research
Phase
Phase 3
Overall status
Terminated
Start date
January 15, 2018
Completion date
April 3, 2019
Enrollment
18 (actual)
Sites
71

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema, diabetic retinopathy